Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
30.09
+1.61 (5.65%)
At close: Aug 13, 2025, 4:00 PM
29.40
-0.69 (-2.29%)
Pre-market: Aug 14, 2025, 8:35 AM EDT
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $2.83 billion as of August 14, 2025. Its market cap has decreased by -33.77% in one year.
Market Cap
2.83B
Enterprise Value
1.69B
1-Year Change
-33.77%
Ranking
Category
Stock Price
$30.09
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $563.93M to $2.83B, an increase of 402.51%. That is a compound annual growth rate of 25.63%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |